Ketter TA - Search Results

1

Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.

Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA. Köhler-Forsberg O, et al. Among authors: ketter ta. J Affect Disord. 2017 Dec 1;223:146-152. doi: 10.1016/j.jad.2017.07.038. Epub 2017 Jul 20. J Affect Disord. 2017. PMID: 28755622 Clinical Trial.

2

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.

Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Corá-Locatelli G, Post RM. Frye MA, et al. Among authors: ketter ta. J Affect Disord. 1998 Mar;48(2-3):91-104. doi: 10.1016/s0165-0327(97)00160-2. J Affect Disord. 1998. PMID: 9543198 Review.

3

Family environment of children and adolescents with bipolar parents.

Chang KD, Blasey C, Ketter TA, Steiner H. Chang KD, et al. Among authors: ketter ta. Bipolar Disord. 2001 Apr;3(2):73-8. doi: 10.1034/j.1399-5618.2001.030205.x. Bipolar Disord. 2001. PMID: 11333066

4

Special issues in the treatment of paediatric bipolar disorder.

Chang KD, Ketter TA. Chang KD, et al. Among authors: ketter ta. Expert Opin Pharmacother. 2001 Apr;2(4):613-22. doi: 10.1517/14656566.2.4.613. Expert Opin Pharmacother. 2001. PMID: 11336611 Review.

5

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression.

Winsberg ME, DeGolia SG, Strong CM, Ketter TA. Winsberg ME, et al. Among authors: ketter ta. J Affect Disord. 2001 Dec;67(1-3):207-12. doi: 10.1016/s0165-0327(01)00434-7. J Affect Disord. 2001. PMID: 11869770 Clinical Trial.

6

Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.

Ketter TA, Calabrese JR. Ketter TA, et al. J Clin Psychiatry. 2002 Feb;63(2):146-51. doi: 10.4088/jcp.v63n0210. J Clin Psychiatry. 2002. PMID: 11874216 Review.

7

Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

Li X, Ketter TA, Frye MA. Li X, et al. Among authors: ketter ta. J Affect Disord. 2002 May;69(1-3):1-14. doi: 10.1016/s0165-0327(00)00361-x. J Affect Disord. 2002. PMID: 12103447 Review.

8

Gabapentin augmentation therapy in bipolar depression.

Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA. Wang PW, et al. Among authors: ketter ta. Bipolar Disord. 2002 Oct;4(5):296-301. doi: 10.1034/j.1399-5618.2002.01211.x. Bipolar Disord. 2002. PMID: 12479661 Clinical Trial.

9

Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.

Janenawasin S, Wang PW, Lembke A, Schumacher M, Das B, Santosa CM, Mongkolcheep J, Ketter TA. Janenawasin S, et al. Among authors: ketter ta. Bipolar Disord. 2002 Oct;4(5):328-34. doi: 10.1034/j.1399-5618.2002.01210.x. Bipolar Disord. 2002. PMID: 12479666 Clinical Trial.

10

Temperament characteristics of child and adolescent bipolar offspring.

Chang KD, Blasey CM, Ketter TA, Steiner H. Chang KD, et al. Among authors: ketter ta. J Affect Disord. 2003 Oct;77(1):11-9. doi: 10.1016/s0165-0327(02)00105-2. J Affect Disord. 2003. PMID: 14550931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page